This website uses cookies to improve the functionality and performance of the website, to better understand how you use AAPA’s website and services, and to provide you with a customized experience. By continuing your use of this website, you consent to this use of cookies. See our Privacy Policy for more information.
Data emerging from CVOTs of glucose lowering drugs are highlighting differences among drugs on cardiovascular disease beyond the effects of glucose lowering. Clinicians will need to change their approach to the management of patients with T2D.
American Heart Month in February is an appropriate time to take stock of PAs’ contributions in cardiac care. According to a 2016 NCCPA survey, 2,600 PAs practice in cardiology and 3,150 PAs practice in cardiothoracic and vascular surgery. PAs are treating heart disease, the leading cause of death in men and women, in inspiring ways.